Edition:
United Kingdom

People: Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

19.90USD
14 Jun 2019
Change (% chg)

$0.15 (+0.76%)
Prev Close
$19.75
Open
$19.76
Day's High
$20.23
Day's Low
$19.55
Volume
32,555
Avg. Vol
31,442
52-wk High
$34.65
52-wk Low
$7.74

Feener, Edward 

Mr. Edward P. Feener Ph.D. is the Chief Scientific Officer of the Company. Edward P. Feener, Ph.D., is a scientific co-founder of KalVista and joined as our Chief Scientific Officer in November 2016. Previously, Dr. Feener was an Associate Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Vascular Cell Biology at Joslin Diabetes Center from July 1989 to October 2016. He has more than 27 years of research experience in vascular biology and diabetic complications. His laboratory identified novel mechanisms of action for the plasma kallikrein system, which are implicated in diabetic macular edema, vascular injury, and angioedema.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --